145 related articles for article (PubMed ID: 37603230)
1. Antifungal Efficacy of Luliconazole in an Experimental Rabbit Model of Fungal Keratitis Caused by Fusarium solani.
Arimoto S; Inagaki K; Todokoro D; Suzuki T; Makimura K; Ishino T
Mycopathologia; 2023 Oct; 188(5):775-782. PubMed ID: 37603230
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.
Todokoro D; Suzuki T; Tamura T; Makimura K; Yamaguchi H; Inagaki K; Akiyama H
Cornea; 2019 Feb; 38(2):238-242. PubMed ID: 30422866
[TBL] [Abstract][Full Text] [Related]
3. Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.
Aung TT; Chor WHJ; Lynn MN; Chan ASY; Tan DTH; Beuerman RW
Eye Contact Lens; 2020 Sep; 46(5):274-280. PubMed ID: 32134799
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical 0.5% povidone-iodine compared to 5% natamycin in fungal keratitis caused by Fusarium solani in a rabbit model: a pilot study.
Oliveira LA; Takata TT; Shiguematsu AI; Melo Júnior LA; Gompertz OF; Sousa LB; Mannis MJ
Arq Bras Oftalmol; 2008; 71(6):860-4. PubMed ID: 19169521
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intrastromal injection of 5% natamycin in experimental fusarium keratitis.
Mimouni M; Tam G; Paitan Y; Kidron D; Segev F
J Ocul Pharmacol Ther; 2014 Sep; 30(7):543-7. PubMed ID: 24919100
[TBL] [Abstract][Full Text] [Related]
8. Antifungal efficacy of natamycin in experimental fusarium solani keratitis.
Dong XH; Gao WJ; He XP
Int J Ophthalmol; 2012; 5(2):143-6. PubMed ID: 22762038
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Clinical Management of
Oliveira Dos Santos C; Kolwijck E; van Rooij J; Stoutenbeek R; Visser N; Cheng YY; Santana NTY; Verweij PE; Eggink CA
Front Cell Infect Microbiol; 2020; 10():133. PubMed ID: 32318355
[No Abstract] [Full Text] [Related]
10.
Oliveira Dos Santos C; Kolwijck E; van der Lee HA; Tehupeiory-Kooreman MC; Al-Hatmi AMS; Matayan E; Burton MJ; Eggink CA; Verweij PE
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182529
[TBL] [Abstract][Full Text] [Related]
11. A novel murine model of Fusarium solani keratitis utilizing fluorescent labeled fungi.
Zhang H; Wang L; Li Z; Liu S; Xie Y; He S; Deng X; Yang B; Liu H; Chen G; Zhao H; Zhang J
Exp Eye Res; 2013 May; 110():107-12. PubMed ID: 23523530
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and oxidative stress in corneal tissue in experimental keratitis due to Fusarium solani: Amelioration following topical therapy with voriconazole and epigallocatechin gallate.
Ruban VV; Archana PT; Sundararajan M; Geraldine P; Thomas PA
Mycoses; 2018 Mar; 61(3):159-171. PubMed ID: 29064157
[TBL] [Abstract][Full Text] [Related]
13. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
Wang L; Wang L; Han L; Yin W
Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.
Zhu Z; Zhang H; Yue J; Liu S; Li Z; Wang L
BMC Ophthalmol; 2018 Mar; 18(1):65. PubMed ID: 29499665
[TBL] [Abstract][Full Text] [Related]
16. Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.
Choi KS; Yoon SC; Rim TH; Han SJ; Kim ED; Seo KY
J Ocul Pharmacol Ther; 2014 Jun; 30(5):381-6. PubMed ID: 24724576
[TBL] [Abstract][Full Text] [Related]
17. The preparation and therapeutic effects of β-glucan-specific nanobodies and nanobody-natamycin conjugates in fungal keratitis.
Liu X; Sui J; Li C; Wang Q; Peng X; Meng F; Xu Q; Jiang N; Zhao G; Lin J
Acta Biomater; 2023 Oct; 169():398-409. PubMed ID: 37579912
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh.
Rahman MR; Johnson GJ; Husain R; Howlader SA; Minassian DC
Br J Ophthalmol; 1998 Aug; 82(8):919-25. PubMed ID: 9828778
[TBL] [Abstract][Full Text] [Related]
19. Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Yavas GF; Oztürk F; Küsbeci T; Cetinkaya Z; Ermis SS; Kiraz N; Inan UU
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):275-9. PubMed ID: 17912543
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
